Immunostimulatory effects of polar glycopeptidolipids of Mycobacterium chelonae for inactivated rabies vaccine

Citation
Dcd. Matos et al., Immunostimulatory effects of polar glycopeptidolipids of Mycobacterium chelonae for inactivated rabies vaccine, VACCINE, 18(20), 2000, pp. 2125-2131
Citations number
28
Categorie Soggetti
Veterinary Medicine/Animal Health",Immunology
Journal title
VACCINE
ISSN journal
0264410X → ACNP
Volume
18
Issue
20
Year of publication
2000
Pages
2125 - 2131
Database
ISI
SICI code
0264-410X(20000414)18:20<2125:IEOPGO>2.0.ZU;2-L
Abstract
Humoral and cellular immune responses were analyzed with Fuenzalida-Palacio s rabies vaccine associated with pGPL-Mc, polar glycopeptidolipids extracte d from Mycobacterium chelonae, aiming at its use as adjuvant. These results were compared to those obtained with BCG, a well-known immunostimulator, u nder the same conditions. Rabies vaccine plus pGPL-Mc (2.5 mg/ kg) induced a significant increase in serum neutralizing activity, in vitro lymphocyte proliferation (spontaneous, specific and mitogen stimulation) and delayed t ype hypersensibility. In addition, pGPL-Mc, as well as BCG, enhanced the Va ccine potency. Our results support further studies to encourage the use of pGPL-Mc as an immunostimulator of veterinary vaccines, before consideration for human vaccines. (C) 2000 Elsevier Science Ltd. All rights reserved.